106 STAT. 4528 PUBLIC LAW 102-573—OCT. 29, 1992 "(29) Reduce the maternal mortality rate to no more than 3.3 per 100,000 live births. "(30) Reduce the incidence of fetal alcohol s3midrome to no more than 2 per 1,000 live births. "(31) Reduce stroke deaths to no more than 20 per 100,000. "(32) Reverse the increase in end-stage renal disease (requiring maintenance dialysis or trsuisplantation) to attain an incidence of no more than 13 per 100,000. "(33) Reduce breast cancer deaths to no more than 20.6 per 100,000 women. "(34) Reduce deaths from cancer of the uterine cervix to no more than 1.3 per 100,000 women. "(35) Reduce colorectal cancer deaths to no more than 13.2 per 100,000. (36) Reduce to no more than 11 percent the proportion of individuals who experience a limitation in major activity due to chronic conditions. "(37) Reduce significant hearing impairment to a prevalence of no more than 82 per 1,000. "(38) Reduce significant visual impairment to a prevalence of no more than 30 per 1,000. "(39) Reduce (uabetes-related deaths to no more than 48 per 100,000. "(40) Reduce diabetes to an incidence of no more than 2.5 per 1,000 £Uid a prevalence of no more than 62 per 1,000. "(41) Reduce the most severe complications of diabetes as follows: "(A) End-stage renal disease, 1.9 per 1,000. "(B) Blindness, 1.4 per 1,000. "(C) Lower extremity amputation, 4.9 per 1,000. "(D) Perinatal mortality, 2 percent. "(E) Major congenital malformations, 4 percent. "(42) Confine annual incidence of diagnosed AIDS cases to no more than 1,000 cases. "(43) Confine the prevalence of HIV infection to no more than 100 per 100,000. "(44) Reduce gonorrhea to an incidence of no more than 225 cases per 100,000. "(45) Reduce chlamydia trachomatis infections, as measured by a decrease in the incidence of nongonococcal urethritis to no more than 170 cases per 100,000. "(46) Reduce primary and secondary s3T)hilis to an incidence of no more than 10 cases per 100,000. "(47) Reduce the incidence of pelvic inflammatory disease, as measured by a reduction in hospitalization for pelvic inflammatory disease to no more than 250 per 100,000 women aged 15 through 44. "(48) Reduce viral hepatitis B infection to no more than 40 per 100,000 cases. "(49) Reduce indigenous cases of vaccine-preventable diseases as follows: "(A) Diphtheria among individuals aged 25 and younger, 0. "(B) Tetanus among individuals aged 25 and younger, 0. "(C) Polio (wild-type virus), 0. "(D) Measles, 0.
�
